| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443019 | European Journal of Cancer | 2014 | 9 Pages |
Abstract
Addition of 40Â mg simvastatin to XP does not increase PFS in our trial, although it does not increase toxicity. Low dose of simvastatin (40Â mg) to chemotherapy is not recommended in untargeted population with AGC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Seung Tae Kim, Jung Hun Kang, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, In Gyu Hwang, Sang-Cheol Lee, Keon-Woo Park, Hyo Rak Lee, Won Ki Kang,